Product InformationRegistration Status: Active
BETASERC 24 TABLET 24mg is approved to be sold in Singapore with effective from 2003-03-24. It is marketed by ABBOTT LABORATORIES (SINGAPORE ) PTE LTD, with the registration number of SIN12235P.
This product contains Betahistine 24mg in the form of TABLET. It is approved for ORAL use.
This product is manufactured by ABBOTT HEALTHCARE SAS in FRANCE.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière's disease. It is also commonly used for patients with balance disorders.
For the reduction of episodes of vertigo association with Ménière's disease.
- When given orally, betahistine is rapidly absorbed from the gastrointestinal tract.
- Betahistine is metabolized primarily into 2-pyridylacetic acid and is subsequently excreted in the urine.
Symptoms of overdose (< 640 mg) include mild to moderate nausea, dry mouth, dyspepsia, abdominal pain and somnolence. More serious complications such as convulsions, pulmonary or cardiac complications, may occur with higher intentional overdoses (> 640 mg).
[2-(2-Pyridyl)ethyl]methylamine | 2-(beta-Methylaminoethyl)pyridine | 2-[2-(Methylamino)ethyl]pyridine | Betahistina | Betahistinum | N-Methyl-2-(2-pyridinyl)ethanamine | N-Methyl-2-pyridineethanamine | Betahistine |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.